Trial intelligence / Profile preview

Single-dose versus extended-dose prophylactic antibiotics for caesarean section

PACTR202609469206556Completed

Sponsor
Dr. Aliyu Ibrahim Maina
Start
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of cefuroxime in surgical site infection (SSI) (2 arms), sponsored by Dr. Aliyu Ibrahim Maina. Primary endpoint: Presence of surgical site infection. Started Jan 2025; status: completed.

02

Drugs

cefuroxime
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on PACTR202609469206556.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202609469206556.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call